Lazard Asset Management’s Corcept Therapeutics CORT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $528K | Sell |
7,212
-12,735
| -64% | -$932K | ﹤0.01% | 1479 |
|
|
2025
Q1 | $2.28M | Sell |
19,947
-53
| -0.3% | -$6.05K | ﹤0.01% | 930 |
|
|
2024
Q4 | $1.01M | Buy |
20,000
+1,410
| +8% | +$70.9K | ﹤0.01% | 1150 |
|
|
2024
Q3 | $859K | Sell |
18,590
-45
| -0.2% | -$2.08K | ﹤0.01% | 1148 |
|
|
2024
Q2 | $605K | Sell |
18,635
-1,866
| -9% | -$60.6K | ﹤0.01% | 1132 |
|
|
2024
Q1 | $516K | Sell |
20,501
-1,133
| -5% | -$28.5K | ﹤0.01% | 1048 |
|
|
2023
Q4 | $702K | Sell |
21,634
-6,771
| -24% | -$220K | ﹤0.01% | 1027 |
|
|
2023
Q3 | $773K | Buy |
28,405
+27,140
| +2,145% | +$739K | ﹤0.01% | 1032 |
|
|
2023
Q2 | $28K | Buy |
+1,265
| New | +$28K | ﹤0.01% | 2022 |
|
|
2023
Q1 | – | Sell |
-2,657
| Closed | -$53K | – | 2336 |
|
|
2022
Q4 | $53K | Buy |
2,657
+321
| +14% | +$6.4K | ﹤0.01% | 1784 |
|
|
2022
Q3 | $59K | Sell |
2,336
-194
| -8% | -$4.9K | ﹤0.01% | 1720 |
|
|
2022
Q2 | $60K | Buy |
2,530
+2,424
| +2,287% | +$57.5K | ﹤0.01% | 1728 |
|
|
2022
Q1 | $2K | Sell |
106
-3,263
| -97% | -$61.6K | ﹤0.01% | 2241 |
|
|
2021
Q4 | $66K | Sell |
3,369
-61,418
| -95% | -$1.2M | ﹤0.01% | 1616 |
|
|
2021
Q3 | $1.27M | Buy |
64,787
+61,490
| +1,865% | +$1.21M | ﹤0.01% | 1003 |
|
|
2021
Q2 | $72K | Hold |
3,297
| – | – | ﹤0.01% | 1444 |
|
|
2021
Q1 | $78K | Hold |
3,297
| – | – | ﹤0.01% | 1265 |
|
|
2020
Q4 | $86K | Sell |
3,297
-753
| -19% | -$19.6K | ﹤0.01% | 1217 |
|
|
2020
Q3 | $70K | Buy |
4,050
+2,225
| +122% | +$38.5K | ﹤0.01% | 1093 |
|
|
2020
Q2 | $30K | Sell |
1,825
-2,592
| -59% | -$42.6K | ﹤0.01% | 1364 |
|
|
2020
Q1 | $52K | Buy |
4,417
+4,168
| +1,674% | +$49.1K | ﹤0.01% | 1159 |
|
|
2019
Q4 | $3K | Buy |
+249
| New | +$3K | ﹤0.01% | 1451 |
|
|
2018
Q1 | – | Sell |
-17,422
| Closed | -$314K | – | 1055 |
|
|
2017
Q4 | $314K | Buy |
+17,422
| New | +$314K | ﹤0.01% | 834 |
|